HR 843
Prompt Approval of Safe Generic Drugs Act
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 6:50 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill, the Prompt Approval of Safe Generic Drugs Act, aims to speed up the approval process for generic drugs. It allows the Food and Drug Administration (FDA) to approve generic drugs even if their labeling doesn't include all the safety information required, as long as that information is protected by patents or exclusivity. The FDA would still be required to add any necessary safety information to the drug’s labeling to ensure safe use, but this would be done after the initial approval.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.